Oral nonstatin medication significantly lowers cholesterol in high-risk patients
1. In this randomized controlled trial, once-daily oral enlicitide was associated with sustained reductions in low-density lipoprotein cholesterol levels compared ...
Tag: hyperlipidemia
Prevalence of common chronic conditions in Medicare Advantage and traditional Medicare beneficiaries
1. In this cross-sectional study, Medicare Advantage (MA) beneficiaries had a similar prevalence of obesity, hypertension, hyperlipidemia, and chronic kidney ...
Plozasiran reduces triglyceride levels in mixed hyperlipidemia
1. In this randomized controlled trial, among patients with mixed hyperlipidemia, plozasiran significantly reduced fasting triglyceride levels compared with placebo. ...
Assessment of lipid biomarker distribution in dried blood spots for newborn screening
1. In a retrospective cohort study, the distribution of low density lipoprotein cholesterol (LDL-C) and apolipoprotein B (ApoB) levels obtained ...
Combination-drug therapy and earlier detection recommended to improve outcomes in heterozygous familial hypercholesterolemia
1. A significantly greater proportion of patients receiving 2-3 lipid lowering medications achieved LDL-cholesterol targets compared to those receiving monotherapy. ...
#VisualAbstract: Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia
1. Inclisiran, a small interfering RNA, therapy was shown to significantly lower levels of low-density lipoprotein (LDL) cholesterol compared to ...
Insclisiran significantly decreases LDL cholesterol in heterozygous familial hypercholesterolemia patients
1. Inclisiran, a small interfering RNA, therapy was shown to significantly lower levels of low-density lipoprotein (LDL) cholesterol compared to ...
#VisualAbstract: Polypill for Cardiovascular Disease Prevention in an Underserved Population
1. In this randomized, controlled trial, patients without cardiovascular disease randomized to receive a polypill containing atorvastatin, amlodipine, losartan, and ...
Polypill effective for blood pressure and cholesterol control in vulnerable population
1. In this randomized, controlled trial, patients without cardiovascular disease randomized to receive a polypill containing atorvastatin, amlodipine, losartan, and ...
